We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.42%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$29.6B
AUM Growth
+$1.62B
Cap. Flow
+$1.32B
Cap. Flow %
4.47%
Top 10 Hldgs %
15.49%
Holding
3,030
New
705
Increased
1,212
Reduced
975
Closed
103

Sector Composition

Rank Sector Weight
1 Healthcare 9.02%
2 Technology 8.84%
3 Financials 8.13%
4 Consumer Staples 8.02%
5 Industrials 7.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BUFF
2526
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
$214K ﹤0.01%
+8,343
New +$160K
ACG
2527
DELISTED
AllianceBernstein Income Fund Inc
ACG
$214K ﹤0.01%
27,303
-7,138
-21% -$55K
BSCO
2528
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
$213K ﹤0.01%
10,338
-5,107
-33% -$102K
NWS icon
2529
News Corp Class B
NWS
$17.5B
$212K ﹤0.01%
+15,975
New +$198K
RLJ icon
2530
RLJ Lodging Trust
RLJ
$1.66B
$212K ﹤0.01%
+9,284
New +$187K
UCB
2531
United Community Banks
UCB
$4.26B
$212K ﹤0.01%
11,503
-2,858
-20% -$50.7K
LTS
2532
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$212K ﹤0.01%
84,813
+113
+0.1% +$266
KND
2533
DELISTED
Kindred Healthcare
KND
$212K ﹤0.01%
+17,187
New +$178K
VLP
2534
DELISTED
Valero Energy Partners LP
VLP
$212K ﹤0.01%
+4,476
New +$208K
CC icon
2535
Chemours
CC
$2.23B
$211K ﹤0.01%
30,144
-175,633
-85% -$883K
DOG
2536
ProShares Short Dow30
DOG
$86.8M
$211K ﹤0.01%
2,404
-188
-7% -$17.6K
POWR
2537
iShares U.S. Power Infrastructure ETF
POWR
$456M
$211K ﹤0.01%
+12,116
New +$195K
UTHR icon
2538
United Therapeutics
UTHR
$22.7B
$211K ﹤0.01%
+1,898
New +$240K
EFII
2539
DELISTED
Electronics for Imaging
EFII
$211K ﹤0.01%
+4,969
New +$203K
CMRE icon
2540
Costamare
CMRE
$1.75B
$210K ﹤0.01%
+23,647
New +$185K
DBO icon
2541
Invesco DB Oil Fund
DBO
$386M
$210K ﹤0.01%
26,978
+1,100
+4% +$8.35K
MHN
2542
DELISTED
BlackRock MuniHoldings New Yrok Quality Fund
MHN
$210K ﹤0.01%
14,000
SEB icon
2543
Seaboard Corp
SEB
$4.01B
$210K ﹤0.01%
+70
New +$196K
AKBA icon
2544
Akebia Therapeutics
AKBA
$236M
$209K ﹤0.01%
23,165
-764
-3% -$6.2K
CBA
2545
DELISTED
ClearBridge American Energy MLP
CBA
$209K ﹤0.01%
+29,901
New +$190K
COKE icon
2546
Coca-Cola Consolidated
COKE
$12.7B
$208K ﹤0.01%
+13,000
New +$221K
AGR
2547
DELISTED
Avangrid, Inc.
AGR
$208K ﹤0.01%
+5,186
New +$203K
WGL
2548
DELISTED
Wgl Holdings
WGL
$208K ﹤0.01%
+2,878
New +$192K
HSNI
2549
DELISTED
HSN, Inc.
HSNI
$208K ﹤0.01%
+3,983
New +$198K
GEF icon
2550
Greif
GEF
$4.95B
$207K ﹤0.01%
+6,328
New +$175K

Similar funds

Raymond James & Associates's Q1 2016 Portfolio in Review

As of Q1 2016, Raymond James & Associates held 3,030 positions worth $29.6B, up 5.8% from $27.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James & Associates deployed $1.32B of net new capital in Q1 2016, opening 705 new positions and adding to 1,212 existing holdings. Its largest new stake was FlexShares Quality Dividend Index Fund: 874,910 shares worth $31.6M.

By sector, the portfolio is most concentrated in Healthcare at 9% of assets, down from 9.6% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $147M trimmed.

  • Raymond James & Associates's largest Q1 2016 buy was FlexShares Quality Dividend Index Fund: 874,910 shares worth $31.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2016, an estimated $132M increase.
  • Raymond James & Associates's biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $147M.
  • Raymond James & Associates fully exited BROADCOM CORP CL-A in Q1 2016, selling an estimated $56.9M.
  • Raymond James & Associates's ten largest holdings make up 15% of its $29.6B portfolio in Q1 2016.
  • Raymond James & Associates opened 705 new positions and closed 103 in Q1 2016.
  • Raymond James & Associates's portfolio value rose 5.8% quarter-over-quarter to $29.6B.

Based on Raymond James & Associates's 13F filing for Q1 2016, filed 12 May 2016.